Life Sciences Insights

PAVmed, Lucid, Veris Axe Workforce by 20%

PAVmed and its subsidiaries, Lucid and Veris, will also implement a strategic plan that will hopefully lower quarterly cash-burn by 25%. PAVmed, a commercial-stage medical technology company, and its majority-owned

Read More »